Patients with inflammatory arthritic diseases harbor elevated serum and synovial fluid levels of free and immune-complexed glucose-6-phosphate isomerase (G6PI)

Biochemical and Biophysical Research Communications

Volumn 349, Issue 2, 2006, Pages 838-845

  Schaller, Monica ^a,e   Stohl, William ^b   Benoit, Vivian ^a   Tan, Soon Min ^b   Johansen, Lene ^c   Ditzel, Henrik J ^a,c,d  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b LAC USC MEDICAL CENTER   (United States)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Enzymatic activity; Glucose 6 phosphate isomerase; Immune complexes; Inflammatory arthritis; Protein composition; Synovial fluid

Indexed keywords

COMPLEMENT COMPONENT C1Q; GLUCOSE 6 PHOSPHATE ISOMERASE; IMMUNOGLOBULIN G ANTIBODY;

ANTIBODY PRODUCTION; ANTIGEN ANTIBODY COMPLEX; ANTIGEN EXPRESSION; ARTHRITIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; JOINT DESTRUCTION; MOLECULAR WEIGHT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SERUM; SPECTROPHOTOMETRY; STATISTICAL ANALYSIS; SYNOVIAL FLUID; WESTERN BLOTTING;

ARTHRITIS; COHORT STUDIES; COMPLEMENT C1Q; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE-6-PHOSPHATE ISOMERASE; HUMANS; IMMUNE SYSTEM; INFLAMMATION; JOINTS; MALE; RECOMBINANT PROTEINS; SYNOVIAL FLUID;

EID: 33748521275     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.08.105     Document Type: Article

References (34)

1. Gurney M.E., Apatoff B.R., Spear G.T., Baumel M.J., Antel J.P., Bania M.B., et al. Neuroleukin: a lymphokine product of lectin-stimulated T cells. Science 234 (1986) 574-581
2. Xu W., Seiter K., Feldman E., Ahmed T., and Chiao J.W. The differentiation and maturation mediator for human myeloid leukemia cells shares homology with neuroleukin or phosphoglucose isomerase. Blood 87 (1996) 4502-4506
3. Watanabe H., Takehana K., Date M., Shinozaki T., and Raz A. Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide. Cancer Res. 56 (1996) 2960-2963
4. Gurney M.E., Heinrich S.P., Lee M.R., and Yin H.S. Molecular cloning and expression of neuroleukin, a neurotrophic factor for spinal and sensory neurons. Science 234 (1986) 566-574
5. Cao M.J., Osatomi K., Matsuda R., Ohkubo M., Hara K., and Ishihara T. Purification of a novel serine proteinase inhibitor from the skeletal muscle of white croaker (Argyrosomus argentatus). Biochem. Biophys. Res. Commun. 272 (2000) 485-489
6. Yakirevich E., and Naot Y. Cloning of a glucose phosphate isomerase/neuroleukin-like sperm antigen involved in sperm agglutination. Biol. Reprod. 62 (2000) 1016-1023
7. Bruch P., Schnackerz K.D., and Gracy R.W. Matrix-bound phosphoglucose isomerase. Formation and properties of monomers and hybrids. Eur. J. Biochem. 68 (1976) 153-158
8. Sun Y.J., Chou C.C., Chen W.S., Wu R.T., Meng M., and Hsiao C.D. The crystal structure of a multifunctional protein: phosphoglucose isomerase/autocrine motility factor/neuroleukin. Proc. Natl. Acad. Sci. USA 96 (1999) 5412-5417
9. Jeffery C.J., Bahnson B.J., Chien W., Ringe D., and Petsko G.A. Crystal structure of rabbit phosphoglucose isomerase, a glycolytic enzyme that moonlights as neuroleukin, autocrine motility factor, and differentiation mediator. Biochemistry 39 (2000) 955-964
10. Davies C., Muirhead H., and Chirgwin J. The structure of human phosphoglucose isomerase complexed with a transition-state analogue. Acta. Crystallogr. D. Biol. Crystallogr. 59 (2003) 1111-1113
11. Watanabe H., Carmi P., Hogan V., Raz T., Silletti S., Nabi I.R., et al. Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor. J. Biol. Chem. 266 (1991) 13442-13448
12. Chou C.C., Sun Y.J., Meng M., and Hsiao C.D. The crystal structure of phosphoglucose isomerase/autocrine motility factor/neuroleukin complexed with its carbohydrate phosphate inhibitors suggests its substrate/receptor recognition. J. Biol. Chem. 2275 (2000) 23154-23160
13. J. Read, J. Pearce, X. Li, H. Muirhead, J. Chirgwin, C. Davies, The crystal structure of human phosphoglucose isomerase at 1.6 A resolution: implications for catalytic mechanism, cytokine activity and haemolytic anaemia, J. Mol. Biol. 309 (2001) 447-463.
14. Matsumoto I., Staub A., Benoist C., and Mathis D. Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science 286 (1999) 1732-1735
15. Schaller M., Stohl W., Tan S.M., Benoit V.M., Hilbert D.M., and Ditzel H.J. Raised levels of anti-glucose-6-phosphate isomerase IgG in serum and synovial fluid from patients with inflammatory arthritis. Ann. Rheum. Dis. 64 (2005) 743-749
16. Schaller M., Burton D.R., and Ditzel H.J. Autoantibodies to GPI in rheumatoid arthritis: linkage between an animal model and human disease. Nat. Immunol. 2 (2001) 746-753
17. Muraki Y., Matsumoto I., Chino Y., Hayashi T., Suzuki E., Goto D., et al. Glucose-6-phosphate isomerase variants play a key role in the generation of anti-GPI antibodies: possible mechanism of autoantibody production. Biochem. Biophys. Res. Commun. 323 (2004) 518-522
18. Matsumoto I., Lee D.M., Goldbach-Mansky R., Sumida T., Hitchon C.A., Schur P.H., et al. Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders. Arthritis Rheum. 48 (2003) 944-954
19. Jouen F., Vittecoq O., Leguillou F., Tabti-Titon I., Menard J.F., Mejjad O., et al. Diagnostic and prognostic values of anti glucose-6-phosphate isomerase antibodies in community-recruited patients with very early arthritis. Clin. Exp. Immunol. 137 (2004) 606-611
20. Herve C.A., Wait R., and Venables P.J. Glucose-6-phosphate isomerase is not a specific autoantigen in rheumatoid arthritis. Rheumatology (Oxford) 42 (2003) 986-988
21. van Gaalen F.A., Toes R.E., Ditzel H.J., Schaller M., Breedveld F.C., Verweij C.L., et al. Association of autoantibodies to glucose-6-phosphate isomerase with extraarticular complications in rheumatoid arthritis. Arthritis Rheum. 50 (2004) 395-399
22. Tan S.M., Xu D., Roschke V., Perry J.W., Arkfeld D.G., Ehresmann G.R., et al. Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis. Arthritis Rheum. 48 (2003) 982-992
23. Schaller M., Benoit V.M., and Ditzel H.J. Response. Nat. Immunol. 3 (2001) 412-413
24. Yanagawa T., Funasaka T., Tsutsumi S., Raz T., Tanaka N., and Raz A. Differential regulation of phosphoglucose isomerase/autocrine motility factor activities by protein kinase CK2 phosphorylation. J. Biol. Chem. 280 (2005) 10419-10426
25. Yoon D.Y., Buchler P., Saarikoski S.T., Hines O.J., Reber H.A., and Hankinson O. Identification of genes differentially induced by hypoxia in pancreatic cancer cells. Biochem. Biophys. Res. Commun. 288 (2001) 882-886
26. Niizeki H., Kobayashi M., Horiuchi I., Akakura N., Chen J., Wang J., et al. Hypoxia enhances the expression of autocrine motility factor and the motility of human pancreatic cancer cells. Br. J. Cancer 86 (2002) 1914-1919
27. Naughton D.P. Hypoxia-induced upregulation of the glycolytic enzyme glucose-6-phosphate isomerase perpetuates rheumatoid arthritis. Med. Hypotheses 60 (2003) 324-332
28. Yarilin D.A., Valiando J., and Posnett D.N. A mouse herpesvirus induces relapse of experimental autoimmune arthritis by infection of the inflammatory target tissue. J. Immunol. 173 (2004) 5238-5246
29. Feldmann M., Brennan F.M., and Maini R.N. Rheumatoid arthritis. Cell 85 (1996) 307-310
30. Kori Y., Matsumoto I., Zhang H., Yasukochi T., Iwanami K., Goto D., Ito S., Tsusumi A., and Sumida T. Characterisation of Th1/Th2 type, glucose-6-phosphate isomerase reactive T cells in the generation of rheumatoid arthritis. Ann. Rheum. Dis. 65 (2006) 968-969
31. Yasasever V., Dincer M., Camlica H., Duranyildiz D., and Dalay N. Evaluation of phosphohexose isomerase as a metastasis marker in breast cancer patients. Eur. J. Gynaecol. Oncol. 18 (1997) 397-399
32. Filell X., Molina R., Jo J., Mas E., and Ballesta A.M. Serum phosphohexose isomerase activities in patients with colorectal cancer. Tumour Biol. 12 (1991) 360-367
33. Baumann M., Kappl A., Lang T., Brand K., Siegfried W., and Paterok E. The diagnostic validity of the serum tumor marker phosphohexose isomerase (PHI) in patients with gastrointestinal, kidney, and breast cancer. Cancer Invest. 8 (1990) 351-356
34. Matsumoto I., Maccioni M., Lee M.D., Maurice M., Simmons B., Brenner M., et al. How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nat. Immunol. 3 (2002) 360-365